Monsenso A/S : Peter Høngaard Andersen and Jacob Hahn Michelsen proposed to join the board of Monsenso

7.1.2021 20:44:53 CET | Monsenso | Chang. board/management/certified advisors

Monsenso today announces that the board of Directors has decided to call for an Extraordinary General Meeting on January 29th, 2021, where two new members are proposed to be elected for the board. Notice to attend the meeting will be issued separately.

Company Announcement no. 1-2021

Copenhagen, 2021.01.07

Monsenso - a leading provider of mobile health solutions for mental health - plans to further strengthen the board by nominating two new professional board members with strong qualifications and competencies to support Monsenso in getting to the next level in the company’s growth journey: Peter Høngaard Andersen, formerly. Managing Director at Innovation Fund Denmark and VP at Lundbeck; Jacob Hahn Michelsen, SVP Private & Public at NNIT A/S.

Current board member Thomas Knudsen has offered to resign from his position on the board at the Extraordinary General Meeting. Thomas has supported Monsenso’s growth for several years from being a university research project spin-out to becoming an international publicly listed company on Nasdaq First North Growth Market Copenhagen. The board and the management of Monsenso would like to thank Thomas Knudsen for his outstanding work. His contributions have been essential in building up the product portfolio, securing the first rounds of financing, supporting the management and finally listing the company.

The new board is planning to constitute itself with Jukka Pertola as the Chairman and Jakob Bardram as the Vice Chairman until the next ordinary Annual General Meeting on April 14, 2021 where Jukka Pertola is expected to resign as the Chairman. Nomination of the new board members in January will help ensure an appropriate introduction, as well as a smooth transition and handover of responsibilities in the period leading up to the Annual General Meeting.

Jukka Pertola commented: ”Since I became a professional board member, I have been lucky to be invited to multiple boards of exciting companies, one of them being Monsenso. However, to address the good corporate governance requirements, I have decided to reduce my number of board positions and chairmanships. We have found an exceptionally strong pair of new board members, who can contribute to bringing Monsenso to the next level. Jacob Hahn Michelsen has extensive experience in pharma- and health-related software and IT, regulatory environment of medical applications and a valuable industry knowhow, while Peter Høngaard brings considerable experience from science and research, pharmaceuticals, neurology, intellectual property rights, innovation and funding.“

Any inquiries regarding this notice should be directed to:

Monsenso:

Chairman of the board
Jukka P. Pertola
Tel. [phone]
E-mail: [e-mail]

CEO
Thomas Lethenborg
Tel. [phone]
E-mail: [e-mail] 

Certified Adviser:

Norden CEF ApS
John Norden
Tel. [phone]
E-mail: [e-mail]

About Monsenso

Monsenso is an innovative technology company offering a mobile Health (mHealth) solution. Our mission is to help provide better mental health to more people at lower costs.  Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com

Attachments

• Download announcement as PDF.pdf

© Ritzau Denmark, source Ritzau English Regulatory Releases